The timing coincides with Zcash's Ironwood upgrade, activated July 28 after a critical vulnerability was discovered in the Orchard shielded pool. Migration to the new pool has moved 3.01 million ZEC — 77.4% of prior Orchard balances — while ZEC has climbed from $480 to above $500, with 24-hour volume reaching $172 million. Network hashrate is also rising as DCG-backed Fortitude pushes its controlled capacity past 60 megawatts across seven sites in five states.
Cypherpunk's dual identity complicates the investment case. Its Leap Therapeutics subsidiary is advancing sirexatamab, an anti-DKK1 antibody, toward a Phase 3 trial in metastatic colorectal cancer after FDA alignment on trial design. Funding that program will require substantial capital — money the company says it may need to raise if ZEC prices don't rebound. Meanwhile, the stock has fallen 40% year-to-date and 96% over five years, trading at a persistent discount to net asset value.
The mining fleet adds a tangible asset base to a story that has been purely financial. Whether that narrows the valuation gap depends on whether mining margins can offset treasury volatility and biotech burn — and whether the market starts pricing CYPH as an infrastructure play rather than a leveraged ZEC fund.
Sources: Source 1 · Source 2 · Source 3 · Source 4 · Source 5 · Source 6
